| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 63 | 2020 | 404 | 9.660 |
Why?
|
| Diabetes Mellitus, Type 1 | 41 | 2021 | 559 | 7.180 |
Why?
|
| Islets of Langerhans | 48 | 2020 | 548 | 7.050 |
Why?
|
| Insulin | 50 | 2020 | 1146 | 4.690 |
Why?
|
| Homeodomain Proteins | 24 | 2017 | 556 | 2.850 |
Why?
|
| Peptide Initiation Factors | 11 | 2020 | 27 | 2.670 |
Why?
|
| Arachidonate 12-Lipoxygenase | 7 | 2019 | 23 | 2.570 |
Why?
|
| Trans-Activators | 19 | 2017 | 443 | 2.460 |
Why?
|
| Unfolded Protein Response | 5 | 2016 | 43 | 2.280 |
Why?
|
| RNA-Binding Proteins | 11 | 2020 | 258 | 2.250 |
Why?
|
| Lysine | 10 | 2020 | 150 | 2.160 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2020 | 191 | 1.870 |
Why?
|
| Transcription, Genetic | 16 | 2015 | 1157 | 1.670 |
Why?
|
| Protein Biosynthesis | 11 | 2018 | 388 | 1.640 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 8 | 2019 | 19 | 1.590 |
Why?
|
| Mice | 68 | 2020 | 11737 | 1.570 |
Why?
|
| Animals | 103 | 2020 | 27317 | 1.520 |
Why?
|
| DNA | 12 | 2018 | 1307 | 1.470 |
Why?
|
| Endoplasmic Reticulum | 5 | 2014 | 255 | 1.460 |
Why?
|
| Arachidonate 15-Lipoxygenase | 5 | 2019 | 15 | 1.390 |
Why?
|
| Glucose | 18 | 2020 | 630 | 1.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 15 | 2020 | 1176 | 1.280 |
Why?
|
| Mice, Inbred NOD | 12 | 2020 | 195 | 1.260 |
Why?
|
| DNA Methylation | 10 | 2020 | 657 | 1.220 |
Why?
|
| Endoplasmic Reticulum Stress | 10 | 2020 | 85 | 1.170 |
Why?
|
| Pancreas | 5 | 2020 | 244 | 1.110 |
Why?
|
| Gene Expression Regulation | 15 | 2019 | 1975 | 1.100 |
Why?
|
| Cell Differentiation | 11 | 2020 | 1521 | 1.060 |
Why?
|
| PPAR gamma | 3 | 2018 | 73 | 1.010 |
Why?
|
| Stem Cell Transplantation | 4 | 2010 | 188 | 1.000 |
Why?
|
| Cell Death | 5 | 2020 | 262 | 0.980 |
Why?
|
| Oxidative Stress | 7 | 2020 | 458 | 0.930 |
Why?
|
| Diet, High-Fat | 6 | 2020 | 117 | 0.910 |
Why?
|
| Proinsulin | 7 | 2019 | 124 | 0.910 |
Why?
|
| Apoptosis | 10 | 2020 | 1716 | 0.900 |
Why?
|
| RNA, Messenger | 13 | 2019 | 2011 | 0.890 |
Why?
|
| Dietary Fats | 4 | 2020 | 135 | 0.890 |
Why?
|
| Palmitic Acid | 2 | 2014 | 27 | 0.890 |
Why?
|
| Diabetes Mellitus | 5 | 2020 | 738 | 0.820 |
Why?
|
| Mice, Inbred C57BL | 20 | 2020 | 3209 | 0.800 |
Why?
|
| Protein Precursors | 4 | 2018 | 140 | 0.790 |
Why?
|
| Lipoxygenase Inhibitors | 3 | 2018 | 33 | 0.790 |
Why?
|
| Euchromatin | 3 | 2009 | 6 | 0.730 |
Why?
|
| Polyamines | 3 | 2019 | 37 | 0.730 |
Why?
|
| Islets of Langerhans Transplantation | 7 | 2021 | 241 | 0.710 |
Why?
|
| Tissue Engineering | 4 | 2013 | 185 | 0.700 |
Why?
|
| Promoter Regions, Genetic | 15 | 2009 | 956 | 0.680 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2015 | 87 | 0.670 |
Why?
|
| Spleen | 1 | 2020 | 432 | 0.650 |
Why?
|
| Cytokines | 6 | 2020 | 802 | 0.630 |
Why?
|
| Naphthalenes | 2 | 2019 | 45 | 0.630 |
Why?
|
| Sex Characteristics | 1 | 2020 | 324 | 0.630 |
Why?
|
| Isoxazoles | 2 | 2019 | 77 | 0.620 |
Why?
|
| Biomarkers | 11 | 2020 | 1755 | 0.620 |
Why?
|
| Hydroxyquinolines | 1 | 2017 | 4 | 0.600 |
Why?
|
| Humans | 80 | 2021 | 89063 | 0.600 |
Why?
|
| Up-Regulation | 5 | 2020 | 727 | 0.590 |
Why?
|
| Stem Cells | 3 | 2015 | 372 | 0.590 |
Why?
|
| Thiophenes | 1 | 2017 | 43 | 0.590 |
Why?
|
| Histones | 4 | 2015 | 329 | 0.570 |
Why?
|
| Blood Glucose | 11 | 2020 | 836 | 0.560 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2019 | 306 | 0.560 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 73 | 0.540 |
Why?
|
| Obesity | 4 | 2020 | 966 | 0.540 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2015 | 161 | 0.540 |
Why?
|
| Chromatin | 5 | 2006 | 397 | 0.530 |
Why?
|
| Cell Proliferation | 10 | 2020 | 1650 | 0.530 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 2362 | 0.530 |
Why?
|
| Mice, Knockout | 16 | 2019 | 1990 | 0.520 |
Why?
|
| Publications | 1 | 2015 | 27 | 0.510 |
Why?
|
| Cell Line | 15 | 2020 | 2495 | 0.510 |
Why?
|
| Science | 1 | 2015 | 34 | 0.510 |
Why?
|
| Signal Transduction | 11 | 2020 | 3373 | 0.500 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 490 | 0.500 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2017 | 173 | 0.490 |
Why?
|
| Models, Biological | 4 | 2017 | 1763 | 0.480 |
Why?
|
| Transcription Factors | 9 | 2020 | 1652 | 0.480 |
Why?
|
| C-Peptide | 8 | 2019 | 179 | 0.480 |
Why?
|
| Medical Laboratory Personnel | 1 | 2014 | 4 | 0.480 |
Why?
|
| Diabetes Complications | 2 | 2018 | 170 | 0.470 |
Why?
|
| Stress, Physiological | 2 | 2015 | 229 | 0.470 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2018 | 185 | 0.460 |
Why?
|
| Liver | 4 | 2017 | 1205 | 0.460 |
Why?
|
| Hyperglycemia | 3 | 2020 | 172 | 0.460 |
Why?
|
| Male | 40 | 2020 | 42251 | 0.460 |
Why?
|
| Inflammation | 5 | 2019 | 971 | 0.460 |
Why?
|
| Protein Methyltransferases | 2 | 2015 | 15 | 0.450 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 9 | 0.450 |
Why?
|
| Second Messenger Systems | 1 | 2013 | 41 | 0.440 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 51 | 0.440 |
Why?
|
| Female | 33 | 2020 | 46011 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2012 | 6 | 0.430 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 108 | 0.420 |
Why?
|
| Th1 Cells | 1 | 2013 | 166 | 0.420 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 92 | 0.420 |
Why?
|
| Cytological Techniques | 1 | 2012 | 30 | 0.420 |
Why?
|
| Triazoles | 1 | 2013 | 102 | 0.420 |
Why?
|
| Collagenases | 1 | 2012 | 41 | 0.420 |
Why?
|
| Cyclic AMP | 1 | 2013 | 274 | 0.410 |
Why?
|
| Transcriptional Activation | 6 | 2012 | 291 | 0.410 |
Why?
|
| Endopeptidases | 1 | 2012 | 117 | 0.410 |
Why?
|
| Regenerative Medicine | 2 | 2009 | 25 | 0.400 |
Why?
|
| Regeneration | 2 | 2010 | 150 | 0.400 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2020 | 661 | 0.400 |
Why?
|
| NIH 3T3 Cells | 7 | 2015 | 110 | 0.390 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 645 | 0.380 |
Why?
|
| Protein Binding | 10 | 2017 | 1487 | 0.380 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 65 | 0.370 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2020 | 83 | 0.360 |
Why?
|
| Glutamate Decarboxylase | 3 | 2019 | 32 | 0.360 |
Why?
|
| Fasting | 4 | 2018 | 163 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2015 | 887 | 0.360 |
Why?
|
| Chromatin Immunoprecipitation | 8 | 2015 | 136 | 0.350 |
Why?
|
| Homeostasis | 4 | 2019 | 413 | 0.340 |
Why?
|
| Immunity, Innate | 3 | 2018 | 429 | 0.330 |
Why?
|
| Organ Transplantation | 2 | 2010 | 275 | 0.330 |
Why?
|
| Receptor, Insulin | 5 | 2014 | 54 | 0.330 |
Why?
|
| Insulin Resistance | 6 | 2018 | 353 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2020 | 128 | 0.320 |
Why?
|
| Manganese | 1 | 2008 | 55 | 0.320 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2010 | 170 | 0.320 |
Why?
|
| Guanine | 3 | 2014 | 207 | 0.310 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 115 | 0.310 |
Why?
|
| RNA, Small Interfering | 6 | 2012 | 557 | 0.300 |
Why?
|
| Immunoblotting | 7 | 2015 | 273 | 0.300 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 2552 | 0.300 |
Why?
|
| Autophagy | 3 | 2018 | 159 | 0.290 |
Why?
|
| Biosensing Techniques | 3 | 2020 | 73 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2019 | 47 | 0.290 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 153 | 0.290 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2016 | 16 | 0.280 |
Why?
|
| Phenotype | 3 | 2015 | 2439 | 0.280 |
Why?
|
| Cells, Cultured | 8 | 2017 | 2880 | 0.270 |
Why?
|
| Physicians | 1 | 2014 | 689 | 0.270 |
Why?
|
| Interleukin-1beta | 5 | 2020 | 82 | 0.270 |
Why?
|
| Response Elements | 2 | 2005 | 65 | 0.270 |
Why?
|
| Calcium | 5 | 2018 | 1172 | 0.260 |
Why?
|
| Endocrinology | 2 | 2020 | 50 | 0.260 |
Why?
|
| Rats | 12 | 2020 | 4040 | 0.260 |
Why?
|
| Receptors, Cell Surface | 3 | 2016 | 289 | 0.260 |
Why?
|
| Macrophages | 3 | 2020 | 571 | 0.260 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 57 | 0.250 |
Why?
|
| Zebrafish | 4 | 2020 | 319 | 0.240 |
Why?
|
| Autoimmunity | 2 | 2019 | 168 | 0.240 |
Why?
|
| Interferon-gamma | 5 | 2020 | 451 | 0.240 |
Why?
|
| Glucose Intolerance | 3 | 2014 | 94 | 0.240 |
Why?
|
| Adult | 16 | 2020 | 26507 | 0.230 |
Why?
|
| Child | 8 | 2020 | 7149 | 0.230 |
Why?
|
| Zebrafish Proteins | 4 | 2020 | 149 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 5 | 2005 | 740 | 0.230 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2016 | 55 | 0.220 |
Why?
|
| Proteomics | 3 | 2020 | 230 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1429 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2020 | 699 | 0.210 |
Why?
|
| Young Adult | 9 | 2020 | 6288 | 0.210 |
Why?
|
| Weight Gain | 2 | 2020 | 119 | 0.200 |
Why?
|
| Aging | 4 | 2016 | 716 | 0.200 |
Why?
|
| Molecular Structure | 2 | 2017 | 289 | 0.200 |
Why?
|
| Gene Targeting | 1 | 2002 | 73 | 0.200 |
Why?
|
| Sulfonamides | 2 | 2017 | 317 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 412 | 0.200 |
Why?
|
| Streptozocin | 3 | 2019 | 55 | 0.190 |
Why?
|
| Lipoxygenases | 1 | 2020 | 3 | 0.190 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 30 | 0.190 |
Why?
|
| TYK2 Kinase | 1 | 2020 | 7 | 0.180 |
Why?
|
| Diet, Western | 1 | 2020 | 38 | 0.180 |
Why?
|
| Tetracycline | 1 | 2020 | 13 | 0.180 |
Why?
|
| Glucose Tolerance Test | 5 | 2016 | 227 | 0.180 |
Why?
|
| Transdermal Patch | 1 | 2020 | 3 | 0.180 |
Why?
|
| Pancreatic Polypeptide-Secreting Cells | 1 | 2020 | 5 | 0.180 |
Why?
|
| Cytoprotection | 1 | 2020 | 47 | 0.180 |
Why?
|
| Organogenesis | 1 | 2020 | 50 | 0.180 |
Why?
|
| Integrases | 1 | 2020 | 62 | 0.180 |
Why?
|
| Nanomedicine | 1 | 2020 | 14 | 0.180 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 25 | 0.180 |
Why?
|
| Glutaminase | 1 | 2020 | 12 | 0.180 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 91 | 0.180 |
Why?
|
| RNA | 2 | 2019 | 578 | 0.170 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 3027 | 0.170 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 51 | 0.170 |
Why?
|
| Mice, Mutant Strains | 4 | 2018 | 231 | 0.170 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 66 | 0.170 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 95 | 0.170 |
Why?
|
| Biomedical Research | 2 | 2014 | 398 | 0.170 |
Why?
|
| Disease Progression | 3 | 2020 | 1488 | 0.170 |
Why?
|
| Intravital Microscopy | 1 | 2019 | 11 | 0.170 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 243 | 0.170 |
Why?
|
| Cell Survival | 4 | 2020 | 982 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 1400 | 0.170 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2018 | 6 | 0.160 |
Why?
|
| Exosomes | 1 | 2019 | 53 | 0.160 |
Why?
|
| Genes, Recessive | 1 | 2019 | 87 | 0.160 |
Why?
|
| Calcium Channels, R-Type | 1 | 2018 | 4 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 266 | 0.160 |
Why?
|
| Adipose Tissue | 3 | 2017 | 259 | 0.160 |
Why?
|
| Immune Reconstitution | 1 | 2018 | 1 | 0.160 |
Why?
|
| Collagen | 1 | 2020 | 293 | 0.160 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 17 | 0.160 |
Why?
|
| Biological Products | 1 | 2021 | 151 | 0.160 |
Why?
|
| Tissue Survival | 1 | 2018 | 13 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 43 | 0.160 |
Why?
|
| Carboxypeptidase H | 2 | 2017 | 12 | 0.160 |
Why?
|
| Transfection | 6 | 2008 | 911 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 266 | 0.160 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2018 | 7 | 0.160 |
Why?
|
| Retina | 2 | 2018 | 219 | 0.150 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 43 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2018 | 72 | 0.150 |
Why?
|
| Graft Survival | 2 | 2020 | 898 | 0.150 |
Why?
|
| Mice, Transgenic | 7 | 2019 | 1574 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2020 | 211 | 0.150 |
Why?
|
| Cadaver | 1 | 2018 | 185 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2020 | 357 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 217 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2011 | 274 | 0.150 |
Why?
|
| Middle Aged | 11 | 2020 | 25863 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 29 | 0.150 |
Why?
|
| Retinal Vessels | 1 | 2018 | 59 | 0.150 |
Why?
|
| Calcitriol | 1 | 2018 | 173 | 0.150 |
Why?
|
| Adenoviridae | 4 | 2008 | 349 | 0.150 |
Why?
|
| Monocytes | 1 | 2018 | 218 | 0.150 |
Why?
|
| Eflornithine | 2 | 2015 | 14 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2018 | 130 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2019 | 551 | 0.140 |
Why?
|
| Interferon-alpha | 1 | 2018 | 226 | 0.140 |
Why?
|
| Base Sequence | 8 | 2010 | 2327 | 0.140 |
Why?
|
| Dysbiosis | 1 | 2018 | 77 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2018 | 371 | 0.140 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 91 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2018 | 261 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2016 | 68 | 0.140 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 15 | 0.140 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 1796 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2018 | 200 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 726 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2014 | 125 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3443 | 0.140 |
Why?
|
| Tissue Donors | 2 | 2018 | 490 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 65 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2012 | 565 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2019 | 459 | 0.130 |
Why?
|
| 5' Untranslated Regions | 2 | 2014 | 51 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 529 | 0.130 |
Why?
|
| Sirolimus | 2 | 2017 | 170 | 0.130 |
Why?
|
| Genetic Vectors | 4 | 2005 | 446 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 155 | 0.130 |
Why?
|
| Sirtuins | 1 | 2016 | 46 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 183 | 0.130 |
Why?
|
| Acetates | 1 | 2015 | 65 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 371 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1214 | 0.130 |
Why?
|
| Leukotriene B4 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Polyribosomes | 1 | 2014 | 20 | 0.120 |
Why?
|
| Acetylation | 2 | 2006 | 132 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 138 | 0.120 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 24 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 65 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2014 | 3 | 0.120 |
Why?
|
| Financing, Government | 1 | 2014 | 24 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2012 | 302 | 0.120 |
Why?
|
| Phenylalanine | 2 | 1991 | 35 | 0.120 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2014 | 48 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 43 | 0.120 |
Why?
|
| Methylation | 3 | 2015 | 268 | 0.120 |
Why?
|
| Peer Review, Research | 1 | 2014 | 36 | 0.120 |
Why?
|
| Qa-SNARE Proteins | 1 | 2014 | 17 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2014 | 152 | 0.120 |
Why?
|
| Caspase 3 | 2 | 2012 | 162 | 0.120 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 36 | 0.110 |
Why?
|
| Students | 1 | 2015 | 169 | 0.110 |
Why?
|
| DNA Repair | 1 | 2016 | 362 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2013 | 261 | 0.110 |
Why?
|
| RNA Interference | 2 | 2012 | 376 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1710 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2005 | 511 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2016 | 599 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 247 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 401 | 0.110 |
Why?
|
| Silicon Dioxide | 1 | 2013 | 40 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 3035 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 177 | 0.110 |
Why?
|
| Oxygenases | 1 | 2013 | 13 | 0.110 |
Why?
|
| omega-N-Methylarginine | 1 | 2012 | 17 | 0.110 |
Why?
|
| Software | 1 | 2017 | 665 | 0.110 |
Why?
|
| Aconitate Hydratase | 1 | 2012 | 11 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 105 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 2062 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2013 | 84 | 0.110 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 35 | 0.110 |
Why?
|
| Cycloheximide | 1 | 2012 | 56 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2019 | 1064 | 0.110 |
Why?
|
| Glucose Transporter Type 2 | 2 | 2010 | 11 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 89 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 1097 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2019 | 342 | 0.110 |
Why?
|
| In Vitro Techniques | 4 | 2018 | 996 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2018 | 794 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2018 | 1855 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2017 | 755 | 0.110 |
Why?
|
| Drug Synergism | 1 | 2013 | 306 | 0.110 |
Why?
|
| CD3 Complex | 1 | 2012 | 134 | 0.110 |
Why?
|
| Career Choice | 1 | 2014 | 148 | 0.100 |
Why?
|
| Adolescent | 5 | 2018 | 9237 | 0.100 |
Why?
|
| Drug Compounding | 1 | 2013 | 80 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2010 | 511 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 1223 | 0.100 |
Why?
|
| Cell Culture Techniques | 2 | 2013 | 192 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2019 | 3717 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2012 | 151 | 0.100 |
Why?
|
| Imidazoles | 1 | 2012 | 148 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1265 | 0.100 |
Why?
|
| Genomics | 1 | 2017 | 761 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 198 | 0.100 |
Why?
|
| Mutation | 3 | 2019 | 4132 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2013 | 277 | 0.100 |
Why?
|
| Mentors | 1 | 2012 | 85 | 0.100 |
Why?
|
| Kinetics | 5 | 2010 | 1528 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 504 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 783 | 0.090 |
Why?
|
| Sepsis | 1 | 2015 | 319 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2010 | 14 | 0.090 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2010 | 10 | 0.090 |
Why?
|
| Education, Medical | 1 | 2014 | 243 | 0.090 |
Why?
|
| Thapsigargin | 1 | 2010 | 55 | 0.090 |
Why?
|
| Curriculum | 1 | 2015 | 567 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 313 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 506 | 0.090 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2010 | 3 | 0.090 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 16 | 0.090 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 321 | 0.090 |
Why?
|
| Probucol | 1 | 2010 | 1 | 0.090 |
Why?
|
| Sequence Deletion | 4 | 2005 | 205 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2018 | 282 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2012 | 337 | 0.090 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2009 | 14 | 0.090 |
Why?
|
| Benzylamines | 1 | 2009 | 16 | 0.090 |
Why?
|
| Protein Conformation | 5 | 2002 | 887 | 0.090 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2009 | 14 | 0.090 |
Why?
|
| Benzoates | 1 | 2009 | 33 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2005 | 944 | 0.090 |
Why?
|
| Glycerides | 1 | 2009 | 17 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2013 | 548 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2010 | 142 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 76 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 465 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 24 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1940 | 0.080 |
Why?
|
| HIV Infections | 1 | 2018 | 835 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2012 | 442 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 19 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 32 | 0.080 |
Why?
|
| Pancreas, Exocrine | 1 | 2008 | 18 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 421 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 80 | 0.080 |
Why?
|
| Antioxidants | 1 | 2010 | 226 | 0.080 |
Why?
|
| United States | 3 | 2021 | 6955 | 0.080 |
Why?
|
| Interleukins | 2 | 2019 | 129 | 0.080 |
Why?
|
| Cholesterol | 1 | 2010 | 357 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2018 | 76 | 0.080 |
Why?
|
| Ornithine Decarboxylase | 2 | 2019 | 9 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2004 | 275 | 0.080 |
Why?
|
| Escherichia coli | 2 | 2004 | 605 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 122 | 0.080 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2007 | 16 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2019 | 171 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 193 | 0.070 |
Why?
|
| Glucagon | 2 | 2005 | 111 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2008 | 114 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 428 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 345 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 277 | 0.070 |
Why?
|
| Heterochromatin | 1 | 2006 | 22 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 73 | 0.070 |
Why?
|
| Luciferases | 2 | 2004 | 128 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2019 | 268 | 0.070 |
Why?
|
| Biological Assay | 2 | 2020 | 79 | 0.070 |
Why?
|
| Nucleosomes | 1 | 2006 | 55 | 0.070 |
Why?
|
| Alleles | 2 | 2019 | 1135 | 0.070 |
Why?
|
| Pedigree | 2 | 2019 | 969 | 0.060 |
Why?
|
| Plasmids | 2 | 2004 | 291 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 112 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2005 | 36 | 0.060 |
Why?
|
| Serine | 1 | 2005 | 104 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 921 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 638 | 0.060 |
Why?
|
| Gene Expression | 4 | 2010 | 1310 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2004 | 280 | 0.060 |
Why?
|
| Oxygen | 3 | 2016 | 742 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 173 | 0.060 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 81 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 400 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 374 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 283 | 0.060 |
Why?
|
| Swine | 2 | 2018 | 581 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 519 | 0.060 |
Why?
|
| Exons | 1 | 2005 | 451 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 33 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 72 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2003 | 29 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 5320 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 308 | 0.050 |
Why?
|
| COS Cells | 2 | 2020 | 167 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2005 | 1130 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 221 | 0.050 |
Why?
|
| Cricetinae | 2 | 2000 | 558 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 1237 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 491 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 111 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 1012 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2018 | 2863 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1993 | 114 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2009 | 695 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1241 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 63 | 0.050 |
Why?
|
| Endocrinologists | 1 | 2020 | 4 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 153 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 31 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 101 | 0.040 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 23 | 0.040 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 5 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2000 | 97 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2020 | 23 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 125 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 39 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2020 | 75 | 0.040 |
Why?
|
| Dogs | 2 | 1991 | 704 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 48 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 102 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 183 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 202 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 91 | 0.040 |
Why?
|
| RNA, Small Untranslated | 1 | 2019 | 15 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 370 | 0.040 |
Why?
|
| Eye Proteins | 2 | 2010 | 128 | 0.040 |
Why?
|
| Allografts | 1 | 2020 | 181 | 0.040 |
Why?
|
| Heptanes | 1 | 2019 | 2 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 1991 | 412 | 0.040 |
Why?
|
| Candida parapsilosis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 30 | 0.040 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2018 | 8 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 126 | 0.040 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 15 | 0.040 |
Why?
|
| Candida albicans | 1 | 2018 | 32 | 0.040 |
Why?
|
| Light | 1 | 2020 | 292 | 0.040 |
Why?
|
| Meals | 1 | 2018 | 22 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 268 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 96 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2019 | 478 | 0.040 |
Why?
|
| Alloxan | 1 | 2018 | 3 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 243 | 0.040 |
Why?
|
| Verrucomicrobia | 1 | 2018 | 2 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2018 | 10 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2018 | 91 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 86 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 138 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 32 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 200 | 0.040 |
Why?
|
| Ganglia, Sensory | 1 | 2018 | 5 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 16 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 28 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2018 | 20 | 0.040 |
Why?
|
| Firmicutes | 1 | 2018 | 15 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 117 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 67 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2018 | 149 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 232 | 0.040 |
Why?
|
| Bacteroidetes | 1 | 2018 | 39 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 301 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 45 | 0.040 |
Why?
|
| Microvessels | 1 | 2018 | 69 | 0.040 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2017 | 15 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2018 | 66 | 0.040 |
Why?
|
| Laser Capture Microdissection | 1 | 2017 | 20 | 0.040 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2017 | 8 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 328 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 73 | 0.040 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 11 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2017 | 10 | 0.040 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2018 | 22 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2017 | 17 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 86 | 0.040 |
Why?
|
| Nitriles | 1 | 2018 | 160 | 0.040 |
Why?
|
| Peptide Synthases | 1 | 1997 | 12 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 103 | 0.040 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 1997 | 11 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 293 | 0.040 |
Why?
|
| Leukocytes | 1 | 2018 | 204 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 81 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 106 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 202 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 87 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2018 | 150 | 0.040 |
Why?
|
| Blood Banks | 1 | 2016 | 7 | 0.030 |
Why?
|
| Haplotypes | 1 | 2019 | 637 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2016 | 32 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2018 | 295 | 0.030 |
Why?
|
| Binding Sites | 3 | 2000 | 1117 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 327 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2017 | 298 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 781 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 82 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 100 | 0.030 |
Why?
|
| Seizures | 1 | 2019 | 306 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 691 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 543 | 0.030 |
Why?
|
| Morpholinos | 1 | 2015 | 13 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 1057 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Spermidine | 1 | 2015 | 13 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2015 | 39 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2015 | 72 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 510 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 779 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 135 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 372 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 53 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 49 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 308 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 594 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1063 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 509 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 771 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 104 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1533 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2014 | 16 | 0.030 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2014 | 12 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 620 | 0.030 |
Why?
|
| Tyrosine | 2 | 1991 | 133 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 481 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 628 | 0.030 |
Why?
|
| Phase Transition | 1 | 2013 | 18 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 32 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2013 | 30 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1182 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 160 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 684 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2752 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2013 | 78 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 35 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1867 | 0.030 |
Why?
|
| Adiposity | 1 | 2013 | 76 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 688 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1993 | 45 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 805 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1043 | 0.030 |
Why?
|
| Necrosis | 1 | 2013 | 209 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2010 | 423 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 901 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 200 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1067 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2476 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 19077 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2013 | 109 | 0.030 |
Why?
|
| Cattle | 2 | 1991 | 375 | 0.030 |
Why?
|
| Mitochondria | 1 | 2016 | 553 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3657 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 122 | 0.020 |
Why?
|
| Electron Transport | 1 | 1991 | 74 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 15 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2011 | 26 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2011 | 50 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1991 | 26 | 0.020 |
Why?
|
| Fructose | 1 | 2011 | 36 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1991 | 245 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3773 | 0.020 |
Why?
|
| Energy Intake | 1 | 2011 | 97 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2010 | 73 | 0.020 |
Why?
|
| PAX6 Transcription Factor | 1 | 2010 | 10 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 387 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1991 | 134 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2010 | 668 | 0.020 |
Why?
|
| Keto Acids | 1 | 2010 | 4 | 0.020 |
Why?
|
| Tolbutamide | 1 | 2010 | 16 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 52 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 638 | 0.020 |
Why?
|
| Diazoxide | 1 | 2010 | 19 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2010 | 22 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2011 | 95 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2009 | 12 | 0.020 |
Why?
|
| Pyruvate Carboxylase | 1 | 2009 | 6 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2009 | 12 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2009 | 23 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2009 | 5 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2009 | 17 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 121 | 0.020 |
Why?
|
| Antigens | 1 | 1991 | 229 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 153 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 284 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 401 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 1989 | 117 | 0.020 |
Why?
|
| Placenta | 1 | 1990 | 179 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 199 | 0.020 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 104 | 0.020 |
Why?
|
| Cyclin A2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cyclin B | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Trefoil Factor-3 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cyclin A | 1 | 2008 | 29 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2009 | 61 | 0.020 |
Why?
|
| Thymidine | 1 | 2008 | 59 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 83 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 442 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 249 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2010 | 343 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 117 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 348 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 434 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2009 | 242 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2009 | 298 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2009 | 319 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 509 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1875 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1991 | 1215 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2009 | 716 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 849 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 11 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2001 | 30 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2001 | 9 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2001 | 34 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 73 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1177 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2001 | 80 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2001 | 119 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2000 | 65 | 0.010 |
Why?
|
| Protein Multimerization | 2 | 1993 | 175 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 203 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 646 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 77 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2000 | 105 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 211 | 0.010 |
Why?
|
| Insecta | 1 | 2000 | 49 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 353 | 0.010 |
Why?
|
| Ammonium Hydroxide | 1 | 1997 | 1 | 0.010 |
Why?
|
| Amino Acid Isomerases | 1 | 1997 | 5 | 0.010 |
Why?
|
| Hydroxides | 1 | 1997 | 9 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 198 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 242 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 58 | 0.010 |
Why?
|
| Ligands | 1 | 1993 | 443 | 0.010 |
Why?
|
| Arrestin | 1 | 1991 | 5 | 0.010 |
Why?
|
| Rhodopsin | 1 | 1991 | 20 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 1990 | 3 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1991 | 85 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1991 | 106 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 887 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1991 | 311 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1990 | 1296 | 0.000 |
Why?
|
| Pregnancy | 1 | 1990 | 3009 | 0.000 |
Why?
|